Byung Tae Choi Selected Research

Byung Tae Choi Research Topics

Disease

22	Neoplasms (Cancer) 07/2022 - 12/2002
17	Ischemic Stroke 07/2022 - 01/2013
13	Infarction (Infarctions) 01/2022 - 08/2011
13	Stroke (Strokes) 01/2022 - 08/2011
12	Brain Ischemia (Cerebral Ischemia) 07/2022 - 08/2011
11	Ischemia 10/2020 - 01/2014
11	Leukemia 08/2013 - 06/2005
10	Brain Injuries (Brain Injury) 01/2020 - 09/2014
8	Carcinoma (Carcinomatosis) 03/2013 - 12/2002
7	Cognitive Dysfunction 01/2022 - 05/2011
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 08/2011
7	Hypoxia (Hypoxemia) 10/2020 - 03/2011
4	Melanoma (Melanoma, Malignant) 01/2020 - 10/2010
3	Brain Diseases (Brain Disorder) 10/2020 - 01/2014
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2007
3	Cerebral Palsy (Spastic Diplegia) 01/2018 - 05/2017
3	Neuroinflammatory Diseases 08/2016 - 01/2015
3	Hypercholesterolemia 09/2014 - 08/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2009 - 11/2007
2	Parkinson Disease (Parkinson's Disease) 05/2022 - 01/2020
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 03/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2006
2	Amyloid Plaque 01/2020 - 06/2006
2	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 11/2015
2	Brain Edema (Cerebral Edema) 03/2016 - 05/2015
2	Edema (Dropsy) 01/2016 - 01/2014
2	Atherosclerosis 09/2014 - 08/2011
2	Necrosis 03/2011 - 05/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2006 - 05/2004
1	Neurobehavioral Manifestations 01/2020
1	Gliosis 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019

Drug/Important Bio-Agent (IBA)

10	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2022 - 01/2013
8	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2008
5	Cilostazol (Pletal)FDA LinkGeneric 02/2017 - 05/2011
5	CaspasesIBA 08/2013 - 06/2005
4	Therapeutic UsesIBA 05/2022 - 01/2020
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 08/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015 - 11/2008
3	Nerve Growth Factors (Neurotrophins)IBA 07/2022 - 01/2020
3	InflammasomesIBA 01/2022 - 11/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2013
3	Aripiprazole (Abilify)FDA Link 01/2018 - 01/2015
3	AntioxidantsIBA 08/2016 - 05/2006
3	Probucol (Lorelco)FDA Link 08/2016 - 08/2011
3	Neuroprotective AgentsIBA 07/2016 - 01/2011
3	LipopolysaccharidesIBA 01/2015 - 05/2004
3	Monophenol Monooxygenase (Tyrosinase)IBA 05/2012 - 10/2010
3	Melanins (Melanin)IBA 05/2012 - 10/2010
3	DNA (Deoxyribonucleic Acid)IBA 03/2008 - 10/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2006 - 06/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2022 - 01/2020
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2022 - 01/2020
2	linderalactoneIBA 01/2020 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2014
2	Amyloid beta-PeptidesIBA 01/2020 - 06/2006
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 05/2006
2	Phosphotransferases (Kinase)IBA 01/2019 - 12/2008
2	Oxygen (Dioxygen)IBA 01/2018 - 03/2013
2	Apolipoproteins E (ApoE)IBA 08/2016 - 08/2011
2	LipidsIBA 08/2016 - 09/2014
2	Glutamic Acid (Glutamate)FDA Link 07/2016 - 06/2015
2	Evans Blue (Blue, Evans)FDA Link 03/2016 - 05/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2015 - 09/2014
2	Peptide Hydrolases (Proteases)FDA Link 11/2015 - 06/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 11/2007
2	CytokinesIBA 01/2015 - 03/2011
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 10/2011 - 03/2008
2	naringeninIBA 02/2011 - 03/2009
2	Biological ProductsIBA 01/2010 - 08/2004
2	esculetinIBA 12/2008 - 03/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2008 - 05/2005
2	CurcuminIBA 09/2007 - 05/2006
2	ResveratrolIBA 06/2006 - 02/2004
2	beta-lapachoneIBA 01/2006 - 11/2003
2	quinone (benzoquinone)IBA 01/2006 - 11/2003
2	Methylnitronitrosoguanidine (MNNG)IBA 06/2005 - 10/2004
2	Alkylating AgentsIBA 06/2005 - 10/2004
2	NF-kappa B (NF-kB)IBA 05/2004 - 11/2003
1	AntigensIBA 07/2022
1	Free Radical ScavengersIBA 07/2022
1	EdaravoneIBA 07/2022
1	Neurotrophin 3IBA 07/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	Insulysin (Insulin-Degrading Enzyme)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	LuciferasesIBA 01/2020

Therapy/Procedure

16	Therapeutics 07/2022 - 08/2011
15	Electroacupuncture 07/2022 - 02/2012
4	Acupuncture Points (Acupuncture Point) 07/2022 - 01/2014
3	Transcranial Direct Current Stimulation 05/2022 - 01/2020
3	Low-Level Light Therapy (LLLT) 01/2022 - 01/2016
2	East Asian Traditional Medicine (Oriental Medicine) 06/2005 - 05/2004